{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:12:53Z","timestamp":1782400373526,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jaad.2018.10.060","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T14:11:06Z","timestamp":1541167866000},"page":"722-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A nomogram to identify high-risk melanoma patients with a negative sentinel lymph node biopsy"],"prefix":"10.1016","volume":"80","author":[{"given":"Eduardo","family":"Bertolli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Petaccia","family":"de Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius Fernando","family":"Calsavara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clovis Antonio Lopes","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Pedreira","family":"Duprat Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.10.060_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.10.060_bib2","first-page":"472","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaad.2018.10.060_bib3","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Melanoma","year":"2018"},{"key":"10.1016\/j.jaad.2018.10.060_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMclde1712449","article-title":"Management of sentinel-node metastasis in melanoma","volume":"378","author":"Caulley","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.10.060_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejca.2017.09.014","article-title":"The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients","volume":"86","author":"Eggermont","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2018.10.060_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5301\/tj.5000298","article-title":"Evaluation of melanoma features and their relationship with nodal disease: the importance of the pathological report","volume":"101","author":"Bertolli","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.jaad.2018.10.060_bib7","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.surg.2015.12.002","article-title":"Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes","volume":"159","author":"Egger","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.jaad.2018.10.060_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1590\/abd1806-4841.20164715","article-title":"Brazilian guidelines for diagnosis, treatment and follow-up of primary cutaneous melanoma - Part II","volume":"91","author":"Castro","year":"2016","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2018.10.060_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjd.12687","article-title":"Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a\u00a0critical appraisal and comprehensive review","volume":"170","author":"Fong","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.060_bib10","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.10.060_bib11","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-Mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.10.060_bib12","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.10.060_bib13","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1097\/01.PRS.0000165279.99067.79","article-title":"Sentinel lymph node biopsy in cutaneous melanoma: analysis of 240 consecutive cases","volume":"115","author":"Duprat","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2018.10.060_bib14","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/PAS.0b013e31829d7f35","article-title":"Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR)","volume":"37","author":"Scolyer","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2018.10.060_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportionnal hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"key":"10.1016\/j.jaad.2018.10.060_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1016\/j.jaad.2018.10.060_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jclinepi.2015.04.005","article-title":"Prediction models need appropriate internal, internal-external, and external validation","volume":"69","author":"Steyerberg","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2018.10.060_bib18","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.10.060_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node\u00a0dissection versus no dissection in patients with sentinel\u00a0lymph\u00a0node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2018.10.060_bib20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(15)00187-4","article-title":"Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02\/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial","volume":"16","author":"Henderson","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2018.10.060_bib21","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1200\/JCO.2006.08.8013","article-title":"Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation","volume":"25","author":"Bevilacqua","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2018.10.060_bib22","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1200\/JCO.2007.15.4179","article-title":"Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma","volume":"26","author":"Gershenwald","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2018.10.060_bib23","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1200\/JCO.2010.30.9567","article-title":"Non-sentinel node risk score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes","volume":"28","author":"Murali","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaad.2018.10.060_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1245\/s10434-017-6143-5","article-title":"Prediction of non-sentinel node status in patients with melanoma and positive sentinel node biopsy: An Italian Melanoma Intergroup (IMI) study","volume":"25","author":"Rossi","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2018.10.060_bib25","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1245\/s10434-018-6377-x","article-title":"Unique genes in tumor-positive sentinel lymph nodes associated with nonsentinel lymph node metastases in melanoma","volume":"25","author":"Egger","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2018.10.060_bib26","first-page":"196","article-title":"Impact of gene expression profiling on decision-making in clinically node negative melanoma patients after surgical staging","volume":"17","author":"Schuitevoerder","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.10.060_bib27","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1126\/science.aaf2834","article-title":"Cancer immunology. The \u201ccancer immunogram\u201d","volume":"352","author":"Blank","year":"2016","journal-title":"Science"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218328317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218328317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:48:14Z","timestamp":1759272494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218328317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0190962218328317"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.10.060","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nomogram to identify high-risk melanoma patients with a negative sentinel lymph node biopsy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.10.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}